ArticleOman medical journal2024
Association Between Long-term Statin Therapy and New-onset Diabetes in Cardiovascular Risk Patients in the UAE.
Article in Oman medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In the UAE, the relationship between long-term statin use and new-onset diabetes mellitus (NODM) has never been studied. Therefore, this study investigates the incidence and risk of NODM among long-term statin-using UAE nationals with cardiovascular risk factors. Methods: We analyzed retrospective data of patients who were initiated on statin therapy from April to December 2008 and followed up till January 2020. Propensity score matching was applied to match statin users to an equal number of nonusers. Multivariable Cox proportional hazards regression analysis estimated the risk of NODM in statin users compared to nonusers. Results: Patients (N = 631) with one or more vascular risk factors were followed for a median of 10.1 years (IQR = 7.9-10.9 years). Age- and sex-adjusted incidence of NODM was higher among statin users than among nonusers (21.2 vs. 8.3 events per 1000 person-years). Statin users were also more than three times as likely to develop NODM over 10 years. We estimated that one in 19.2 patients (95% CI: 10.9-90.9) treated with statins for 10 years may develop NODM. Conclusions: Long-term statin use in Emirati patients is associated with an increased NODM risk. Though this risk is small relative to the anti-cardiovascular disease benefits of statins, clinicians should regularly monitor users of statin therapy for early indications of diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.